By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Akebia Therapeutics, Inc. 

9987 Carver Road
Suite 420
Cincinnati  Ohio  45242  U.S.A.
Phone: 513-618-0931 Fax: 513-618-0950


SEARCH JOBS








Company News
Akebia Therapeutics, Inc. (AKBA) Announces Presentation Of Phase 2b Data For AKB-6548 In Non-Dialysis Patients With Anemia Related To Chronic Kidney Disease At The 52nd ERA-EDTA Congress 5/29/2015 11:29:49 AM
Akebia Therapeutics, Inc. (AKBA) Announces Presentation Of Phase 2b Data For AKB-6548 In Non-Dialysis Patients With Anemia Related To Chronic Kidney Disease At The 52nd ERA-EDTA Congress 5/29/2015 9:29:10 AM
Akebia Therapeutics, Inc. (AKBA) To Present At The Jefferies and Co. 2015 Global Healthcare Conference 5/27/2015 10:56:58 AM
Akebia Therapeutics, Inc. (AKBA) Announces Presentation Of AKB-6548 Phase 2b Data At The 52nd ERA-EDTA Annual Congress 5/26/2015 10:58:10 AM
Akebia Therapeutics, Inc. (AKBA) To Present At The 2015 UBS Global Healthcare Conference 5/12/2015 11:21:31 AM
Akebia Therapeutics, Inc. (AKBA) Announces First Quarter 2015 Financial Results 5/11/2015 11:50:02 AM
Akebia Therapeutics, Inc. (AKBA) Announces Closing Of Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 4/23/2015 11:22:36 AM
Akebia Therapeutics, Inc. (AKBA) Prices Public Offering Of Common Stock 4/17/2015 11:25:00 AM
Akebia Therapeutics, Inc. (AKBA) Announces Proposed Public Offering Of Common Stock 4/15/2015 12:38:38 PM
Akebia Therapeutics, Inc. (AKBA) Announces Presentation Of Results From Its Phase IIb Study Of AKB-6548 In Non-Dialysis Patients With Anemia Related To Chronic Kidney Disease At International Society of Nephrology’s World Congress Of Nephrology 3/16/2015 11:01:49 AM
123456
//-->